Spirostanyl glycosidal crystals
US5804562A · kind A · utility
2Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 1997 |
| Grant date | Sep 8, 1998 |
| Priority date | — |
| Expiry date | May 1, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Crystalline spirostanyl glycosides and processes for making them are disclosed. The crystalline spirostanyl glycosides are useful for treatment of hypercholesterolemia or atherosclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.